Relistor
NDC 65649-150, Methylnaltrexone bromide, tablet, from Salix Pharmaceuticals, Inc..
- Product NDC
- 65649-150
- Status
- Listed
- Labeler
- Salix Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208271
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65649-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLNALTREXONE BROMIDE150 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Quaternary Ammonium Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65649-150-06 | 65649015006 | 1 BOTTLE in 1 CARTON (65649-150-06) / 6 TABLET in 1 BOTTLE |
| 65649-150-90 | 65649015090 | 90 TABLET in 1 BOTTLE (65649-150-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c488fb7c-0a5b-487c-b452-996809d1cb99
Use it
Look up 65649-150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65649-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65649-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.